Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Eli Lilly makes $7.8bn takeover play for Centessa

 March 31, 2026

Pharmaphorum

Sleep disorder specialist Centessa is heading for an acquisition by Eli Lilly, which has offered $6.3bn for the US and UK-based biotech.

M&A / DealsRead full story

Post navigation

Merck strikes deal with antibody discovery startup →
← Biogen swoops on Apellis with $5.6bn offer

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com